For Healthcare Professionals
New Treatment
Redemplo (plozasiran injection) is indicated as an adjunct to diet to reduce triglyceride levels for adult patients with familial chylomicronemia syndrome (FCS) for whom standard triglyceride lowering therapies have been inadequate.
Redemplo is administered as a 25 mg single subcutaneous injection every 3 months.
Consult the Product Monograph for important information regarding contraindications, warnings, precautions, adverse reactions, interactions, dosing and conditions of clinical use.
Reference: REDEMPLO Product Monograph. Arrowhead Pharmaceuticals. January 2, 2026.